““People with depression are up to 72% more at risk to develop cardiovascular disease (CVD) in their lifetime. These findings are important as they suggest that successful outcomes of evidence-based psychological interventions may extend beyond psychological health and have long-term physical health benefits, particularly for those aged under 60.”
"Obesity is a difficult-to-manage disease, and it's even more difficult for people living with type 2 diabetes. The degree of mean weight reduction seen in SURMOUNT-2 has not been previously achieved in phase 3 trials for obesity or overweight and type 2 diabetes." More than 80% of tirzepatide users in the SURMOUNT-2 trial lost ≥5% of baseline body weight.
“The effectiveness of these interventions that targeted all or any needed cancer screenings simultaneously offered an approach that can be delivered remotely to rural women and has paved the way to approach preventive health care holistically, fostering cancer prevention and early detection when a cure is realistic and ultimately decreasing cancer health disparities.
Infants born with neonatal opioid withdrawal syndrome cared for with the “Eat, Sleep, Console” (ESC) approach were 63% less likely to receive medication as part of treatment and were discharged home approximately 6.7 days earlier compared to neonates who received standard of care. ESC relies on a function-based vs extensive scoring-based approach to assessment and management of neonatal abstinence syndrome.
“We have shown for the first time that rehospitalizations following heart attacks in women aged 55 and younger are accompanied by certain non-cardiac factors that appear more common in women than men and are associated with more adverse outcomes. The study reveals a need for paying greater attention to these noncardiac risk factors in younger women in order help design better clinical interventions and improve outcomes after discharge for a heart attack.”
Primary Viewpoints Episode 7: Antidepressants for Back Pain, Osteoarthritis Pain
February 25th 2021Listen to our newest podcast episode where the lead author of a recent meta-analysis shares his findings on the safety and efficacy of antidepressant medications to treat back and osteoarthritis pain.